Is Universal Patient Access to Fulvestrant in Hormone Receptor-positive Advanced Breast Cancer Justified? A UK Retrospective Multicentre Study. Issue 8 (August 2020) - Lerner, A.; Keshwani, K.; Sanderson, B.; Board, R.E.; Flynn, M.; Sharkey, E.; Okines, A.; Konstantis, A.; Roylance, R.; Hanna, D.; King, J.; Murphy, R.; et al.